ATX amplia therapeutics limited

Ann: Preliminary Final Report and Annual Report YE 31 March 2024, page-5

  1. 2,997 Posts.
    lightbulb Created with Sketch. 224
    there are initial efficacy signs already and they are already indicating that it will go to phase 2b.... if the phase 2 a data is more promising than phase 1b then game on I would say
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
23.8¢
Change
-0.003(1.04%)
Mkt cap ! $116.7M
Open High Low Value Volume
24.5¢ 24.5¢ 23.8¢ $900.9K 3.728M

Buyers (Bids)

No. Vol. Price($)
16 248135 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 80927 6
View Market Depth
Last trade - 15.49pm 31/07/2025 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.